In contrast, when these patients were stratified by IL-17, those with higher IL-17 level have higher cumulative incidence of HCC (Fig. 2b), demonstrating the usefulness of IL-17 as the second biomarker in the hierarchical patient stratification. The gene discussed is IL17A; the disease is hepatocellular carcinoma.